Kaken Pharmaceutical (4521.TSE) Q1 2025 Earnings

Feb 6Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
42
145
248
351

Details

Expected EPS
N/A
Actual EPS
124
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Kaken Pharmaceutical⁩ (⁦4521.TSE⁩) has reported earnings of ⁦124⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts